Tag Archives: wrong

#437103 How to Make Sense of Uncertainty in a ...

Posted on May 1, 2020 by Android

As the internet churns with information about Covid-19, about the virus that causes the disease, and about what we’re supposed to do to fight it, it can be difficult to see the forest for the trees. What can we realistically expect for the rest of 2020? And how do we even know what’s realistic?

Today, humanity’s primary, ideal goal is to eliminate the virus, SARS-CoV-2, and Covid-19. Our second-choice goal is to control virus transmission. Either way, we have three big aims: to save lives, to return to public life, and to keep the economy functioning.

To hit our second-choice goal—and maybe even our primary goal—countries are pursuing five major public health strategies. Note that many of these advances cross-fertilize: for example, advances in virus testing and antibody testing will drive data-based prevention efforts.

Five major public health strategies are underway to bring Covid-19 under control and to contain the spread of SARS-CoV-2.
These strategies arise from things we can control based on the things that we know at any given moment. But what about the things we can’t control and don’t yet know?

The biology of the virus and how it interacts with our bodies is what it is, so we should seek to understand it as thoroughly as possible. How long any immunity gained from prior infection lasts—and indeed whether people develop meaningful immunity at all after infection—are open questions urgently in need of greater clarity. Similarly, right now it’s important to focus on understanding rather than making assumptions about environmental factors like seasonality.

But the biggest question on everyone’s lips is, “When?” When will we see therapeutic progress against Covid-19? And when will life get “back to normal”? There are lots of models out there on the internet; which of those models are right? The simple answer is “none of them.” That’s right—it’s almost certain that every model you’ve seen is wrong in at least one detail, if not all of them. But modeling is meant to be a tool for deeper thinking, a way to run mental (and computational) experiments before—and while—taking action. As George E. P. Box famously wrote in 1976, “All models are wrong, but some are useful.”

Here, we’re seeking useful insights, as opposed to exact predictions, which is why we’re pulling back from quantitative details to get at the mindsets that will support agency and hope. To that end, I’ve been putting together timelines that I believe will yield useful expectations for the next year or two—and asking how optimistic I need to be in order to believe a particular timeline.

For a moderately optimistic scenario to be relevant, breakthroughs in science and technology come at paces expected based on previous efforts and assumptions that turn out to be basically correct; accessibility of those breakthroughs increases at a reasonable pace; regulation achieves its desired effects, without major surprises; and compliance with regulations is reasonably high.

In contrast, if I’m being highly optimistic, breakthroughs in science and technology and their accessibility come more quickly than they ever have before; regulation is evidence-based and successful in the first try or two; and compliance with those regulations is high and uniform. If I’m feeling not-so-optimistic, then I anticipate serious setbacks to breakthroughs and accessibility (with the overturning of many important assumptions), repeated failure of regulations to achieve their desired outcomes, and low compliance with those regulations.

The following scenarios outline the things that need to happen in the fight against Covid-19, when I expect to see them, and how confident I feel in those expectations. They focus on North America and Europe because there are data missing about China’s 2019 outbreak and other regions are still early in their outbreaks. Perhaps the most important thing to keep in mind throughout: We know more today than we did yesterday, but we still have much to learn. New knowledge derived from greater study and debate will almost certainly inspire ongoing course corrections.

As you dive into the scenarios below, practice these three mindset shifts. First, defeating Covid-19 will be a marathon, not a sprint. We shouldn’t expect life to look like 2019 for the next year or two—if ever. As Ed Yong wrote recently in The Atlantic, “There won’t be an obvious moment when everything is under control and regular life can safely resume.” Second, remember that you have important things to do for at least a year. And third, we are all in this together. There is no “us” and “them.” We must all be alert, responsive, generous, and strong throughout 2020 and 2021—and willing to throw away our assumptions when scientific evidence invalidates them.

The Middle Way: Moderate Optimism
Let’s start with the case in which I have the most confidence: moderate optimism.

This timeline considers milestones through late 2021, the earliest that I believe vaccines will become available. The “normal” timeline for developing a vaccine for diseases like seasonal flu is 18 months, which leads to my projection that we could potentially have vaccines as soon as 18 months from the first quarter of 2020. While Melinda Gates agrees with that projection, others (including AI) believe that 3 to 5 years is far more realistic, based on past vaccine development and the need to test safety and efficacy in humans. However, repurposing existing vaccines against other diseases—or piggybacking off clever synthetic platforms—could lead to vaccines being available sooner. I tried to balance these considerations for this moderately optimistic scenario. Either way, deploying vaccines at the end of 2021 is probably much later than you may have been led to believe by the hype engine. Again, if you take away only one message from this article, remember that the fight against Covid-19 is a marathon, not a sprint.

Here, I’ve visualized a moderately optimistic scenario as a baseline. Think of these timelines as living guides, as opposed to exact predictions. There are still many unknowns. More or less optimistic views (see below) and new information could shift these timelines forward or back and change the details of the strategies.
Based on current data, I expect that the first wave of Covid-19 cases (where we are now) will continue to subside in many areas, leading governments to ease restrictions in an effort to get people back to work. We’re already seeing movement in that direction, with a variety of benchmarks and changes at state and country levels around the world. But depending on the details of the changes, easing restrictions will probably cause a second wave of sickness (see Germany and Singapore), which should lead governments to reimpose at least some restrictions.

In tandem, therapeutic efforts will be transitioning from emergency treatments to treatments that have been approved based on safety and efficacy data in clinical trials. In a moderately optimistic scenario, assuming clinical trials currently underway yield at least a few positive results, this shift to mostly approved therapies could happen as early as the third or fourth quarter of this year and continue from there. One approval that should come rather quickly is for plasma therapies, in which the blood from people who have recovered from Covid-19 is used as a source of antibodies for people who are currently sick.

Companies around the world are working on both viral and antibody testing, focusing on speed, accuracy, reliability, and wide accessibility. While these tests are currently being run in hospitals and research laboratories, at-home testing is a critical component of the mass testing we’ll need to keep viral spread in check. These are needed to minimize the impact of asymptomatic cases, test the assumption that infection yields resistance to subsequent infection (and whether it lasts), and construct potential immunity passports if this assumption holds. Testing is also needed for contact tracing efforts to prevent further spread and get people back to public life. Finally, it’s crucial to our fundamental understanding of the biology of SARS-CoV-2 and Covid-19.

We need tests that are very reliable, both in the clinic and at home. So, don’t go buying any at-home test kits just yet, even if you find them online. Wait for reliable test kits and deeper understanding of how a test result translates to everyday realities. If we’re moderately optimistic, in-clinic testing will rapidly expand this quarter and/or next, with the possibility of broadly available, high-quality at-home sampling (and perhaps even analysis) thereafter.

Note that testing is not likely to be a “one-and-done” endeavor, as a person’s infection and immunity status change over time. Expect to be testing yourself—and your family—often as we move later into 2020.

Testing data are also going to inform distancing requirements at the country and local levels. In this scenario, restrictions—at some level of stringency—could persist at least through the end of 2020, as most countries are way behind the curve on testing (Iceland is an informative exception). Governments will likely continue to ask citizens to work from home if at all possible; to wear masks or face coverings in public; to employ heightened hygiene and social distancing in workplaces; and to restrict travel and social gatherings. So while it’s likely we’ll be eating in local restaurants again in 2020 in this scenario, at least for a little while, it’s not likely we’ll be heading to big concerts any time soon.

The Extremes: High and Low Optimism
How would high and low levels of optimism change our moderately optimistic timeline? The milestones are the same, but the time required to achieve them is shorter or longer, respectively. Quantifying these shifts is less important than acknowledging and incorporating a range of possibilities into our view. It pays to pay attention to our bias. Here are a few examples of reasonable possibilities that could shift the moderately optimistic timeline.

When vaccines become available
Vaccine repurposing could shorten the time for vaccines to become available; today, many vaccine candidates are in various stages of testing. On the other hand, difficulties in manufacture and distribution, or faster-than-expected mutation of SARS-CoV-2, could slow vaccine development. Given what we know now, I am not strongly concerned about either of these possibilities—drug companies are rapidly expanding their capabilities, and viral mutation isn’t an urgent concern at this time based on sequencing data—but they could happen.

At first, governments will likely supply vaccines to essential workers such as healthcare workers, but it is essential that vaccines become widely available around the world as quickly and as safely as possible. Overall, I suggest a dose of skepticism when reading highly optimistic claims about a vaccine (or multiple vaccines) being available in 2020. Remember, a vaccine is a knockout punch, not a first line of defense for an outbreak.

When testing hits its stride
While I am confident that testing is a critical component of our response to Covid-19, reliability is incredibly important to testing for SARS-CoV-2 and for immunity to the disease, particularly at home. For an individual, a false negative (being told you don’t have antibodies when you really do) could be just as bad as a false positive (being told you do have antibodies when you really don’t). Those errors are compounded when governments are trying to make evidence-based policies for social and physical distancing.

If you’re highly optimistic, high-quality testing will ramp up quickly as companies and scientists innovate rapidly by cleverly combining multiple test modalities, digital signals, and cutting-edge tech like CRISPR. Pop-up testing labs could also take some pressure off hospitals and clinics.

If things don’t go well, reliability issues could hinder testing, manufacturing bottlenecks could limit availability, and both could hamstring efforts to control spread and ease restrictions. And if it turns out that immunity to Covid-19 isn’t working the way we assumed, then we must revisit our assumptions about our path(s) back to public life, as well as our vaccine-development strategies.

How quickly safe and effective treatments appear
Drug development is known to be long, costly, and fraught with failure. It’s not uncommon to see hope in a drug spike early only to be dashed later on down the road. With that in mind, the number of treatments currently under investigation is astonishing, as is the speed through which they’re proceeding through testing. Breakthroughs in a therapeutic area—for example in treating the seriously ill or in reducing viral spread after an infection takes hold—could motivate changes in the focus of distancing regulations.

While speed will save lives, we cannot overlook the importance of knowing a treatment’s efficacy (does it work against Covid-19?) and safety (does it make you sick in a different, or worse, way?). Repurposing drugs that have already been tested for other diseases is speeding innovation here, as is artificial intelligence.

Remarkable collaborations among governments and companies, large and small, are driving innovation in therapeutics and devices such as ventilators for treating the sick.

Whether government policies are effective and responsive
Those of us who have experienced lockdown are eager for it to be over. Businesses, economists, and governments are also eager to relieve the terrible pressure that is being exerted on the global economy. However, lifting restrictions will almost certainly lead to a resurgence in sickness.

Here, the future is hard to model because there are many, many factors at play, and at play differently in different places—including the extent to which individuals actually comply with regulations.

Reliable testing—both in the clinic and at home—is crucial to designing and implementing restrictions, monitoring their effectiveness, and updating them; delays in reliable testing could seriously hamper this design cycle. Lack of trust in governments and/or companies could also suppress uptake. That said, systems are already in place for contact tracing in East Asia. Other governments could learn important lessons, but must also earn—and keep—their citizens’ trust.

Expect to see restrictions descend and then lift in response to changes in the number of Covid-19 cases and in the effectiveness of our prevention strategies. Also expect country-specific and perhaps even area-specific responses that differ from each other. The benefit of this approach? Governments around the world are running perhaps hundreds of real-time experiments and design cycles in balancing health and the economy, and we can learn from the results.

A Way Out
As Jeremy Farrar, head of the Wellcome Trust, told Science magazine, “Science is the exit strategy.” Some of our greatest technological assistance is coming from artificial intelligence, digital tools for collaboration, and advances in biotechnology.

Our exit strategy also needs to include empathy and future visioning—because in the midst of this crisis, we are breaking ground for a new, post-Covid future.

What do we want that future to look like? How will the hard choices we make now about data ethics impact the future of surveillance? Will we continue to embrace inclusiveness and mass collaboration? Perhaps most importantly, will we lay the foundation for successfully confronting future challenges? Whether we’re thinking about the next pandemic (and there will be others) or the cascade of catastrophes that climate change is bringing ever closer—it’s important to remember that we all have the power to become agents of that change.

Special thanks to Ola Kowalewski and Jason Dorrier for significant conversations.

Image Credit: Drew Beamer / Unsplash Continue reading →

Posted in Human Robots

#436977 The Top 100 AI Startups Out There Now, ...

Posted on March 30, 2020 by Android

New drug therapies for a range of chronic diseases. Defenses against various cyber attacks. Technologies to make cities work smarter. Weather and wildfire forecasts that boost safety and reduce risk. And commercial efforts to monetize so-called deepfakes.

What do all these disparate efforts have in common? They’re some of the solutions that the world’s most promising artificial intelligence startups are pursuing.

Data research firm CB Insights released its much-anticipated fourth annual list of the top 100 AI startups earlier this month. The New York-based company has become one of the go-to sources for emerging technology trends, especially in the startup scene.

About 10 years ago, it developed its own algorithm to assess the health of private companies using publicly-available information and non-traditional signals (think social media sentiment, for example) thanks to more than $1 million in grants from the National Science Foundation.

It uses that algorithm-generated data from what it calls a company’s Mosaic score—pulling together information on market trends, money, and momentum—along with other details ranging from patent activity to the latest news analysis to identify the best of the best.

“Our final list of companies is a mix of startups at various stages of R&D and product commercialization,” said Deepashri Varadharajanis, a lead analyst at CB Insights, during a recent presentation on the most prominent trends among the 2020 AI 100 startups.

About 10 companies on the list are among the world’s most valuable AI startups. For instance, there’s San Francisco-based Faire, which has raised at least $266 million since it was founded just three years ago. The company offers a wholesale marketplace that uses machine learning to match local retailers with goods that are predicted to sell well in their specific location.

Image courtesy of CB Insights
Funding for AI in Healthcare
Another startup valued at more than $1 billion, referred to as a unicorn in venture capital speak, is Butterfly Network, a company on the East Coast that has figured out a way to turn a smartphone phone into an ultrasound machine. Backed by $350 million in private investments, Butterfly Network uses AI to power the platform’s diagnostics. A more modestly funded San Francisco startup called Eko is doing something similar for stethoscopes.

In fact, there are more than a dozen AI healthcare startups on this year’s AI 100 list, representing the most companies of any industry on the list. In total, investors poured about $4 billion into AI healthcare startups last year, according to CB Insights, out of a record $26.6 billion raised by all private AI companies in 2019. Since 2014, more than 4,300 AI startups in 80 countries have raised about $83 billion.

One of the most intensive areas remains drug discovery, where companies unleash algorithms to screen potential drug candidates at an unprecedented speed and breadth that was impossible just a few years ago. It has led to the discovery of a new antibiotic to fight superbugs. There’s even a chance AI could help fight the coronavirus pandemic.

There are several AI drug discovery startups among the AI 100: San Francisco-based Atomwise claims its deep convolutional neural network, AtomNet, screens more than 100 million compounds each day. Cyclica is an AI drug discovery company in Toronto that just announced it would apply its platform to identify and develop novel cannabinoid-inspired drugs for neuropsychiatric conditions such as bipolar disorder and anxiety.

And then there’s OWKIN out of New York City, a startup that uses a type of machine learning called federated learning. Backed by Google, the company’s AI platform helps train algorithms without sharing the necessary patient data required to provide the sort of valuable insights researchers need for designing new drugs or even selecting the right populations for clinical trials.

Keeping Cyber Networks Healthy
Privacy and data security are the focus of a number of AI cybersecurity startups, as hackers attempt to leverage artificial intelligence to launch sophisticated attacks while also trying to fool the AI-powered systems rapidly coming online.

“I think this is an interesting field because it’s a bit of a cat and mouse game,” noted Varadharajanis. “As your cyber defenses get smarter, your cyber attacks get even smarter, and so it’s a constant game of who’s going to match the other in terms of tech capabilities.”

Few AI cybersecurity startups match Silicon Valley-based SentinelOne in terms of private capital. The company has raised more than $400 million, with a valuation of $1.1 billion following a $200 million Series E earlier this year. The company’s platform automates what’s called endpoint security, referring to laptops, phones, and other devices at the “end” of a centralized network.

Fellow AI 100 cybersecurity companies include Blue Hexagon, which protects the “edge” of the network against malware, and Abnormal Security, which stops targeted email attacks, both out of San Francisco. Just down the coast in Los Angeles is Obsidian Security, a startup offering cybersecurity for cloud services.

Deepfakes Get a Friendly Makeover
Deepfakes of videos and other types of AI-manipulated media where faces or voices are synthesized in order to fool viewers or listeners has been a different type of ongoing cybersecurity risk. However, some firms are swapping malicious intent for benign marketing and entertainment purposes.

Now anyone can be a supermodel thanks to Superpersonal, a London-based AI startup that has figured out a way to seamlessly swap a user’s face onto a fashionista modeling the latest threads on the catwalk. The most obvious use case is for shoppers to see how they will look in a particular outfit before taking the plunge on a plunging neckline.

Another British company called Synthesia helps users create videos where a talking head will deliver a customized speech or even talk in a different language. The startup’s claim to fame was releasing a campaign video for the NGO Malaria Must Die showing soccer star David Becham speak in nine different languages.

There’s also a Seattle-based company, Wellsaid Labs, which uses AI to produce voice-over narration where users can choose from a library of digital voices with human pitch, emphasis, and intonation. Because every narrator sounds just a little bit smarter with a British accent.

AI Helps Make Smart Cities Smarter
Speaking of smarter: A handful of AI 100 startups are helping create the smart city of the future, where a digital web of sensors, devices, and cloud-based analytics ensure that nobody is ever stuck in traffic again or without an umbrella at the wrong time. At least that’s the dream.

A couple of them are directly connected to Google subsidiary Sidewalk Labs, which focuses on tech solutions to improve urban design. A company called Replica was spun out just last year. It’s sort of SimCity for urban planning. The San Francisco startup uses location data from mobile phones to understand how people behave and travel throughout a typical day in the city. Those insights can then help city governments, for example, make better decisions about infrastructure development.

Denver-area startup AMP Robotics gets into the nitty gritty details of recycling by training robots on how to recycle trash, since humans have largely failed to do the job. The U.S. Environmental Protection Agency estimates that only about 30 percent of waste is recycled.

Some people might complain that weather forecasters don’t even do that well when trying to predict the weather. An Israeli AI startup, ClimaCell, claims it can forecast rain block by block. While the company taps the usual satellite and ground-based sources to create weather models, it has developed algorithms to analyze how precipitation and other conditions affect signals in cellular networks. By analyzing changes in microwave signals between cellular towers, the platform can predict the type and intensity of the precipitation down to street level.

And those are just some of the highlights of what some of the world’s most promising AI startups are doing.

“You have companies optimizing mining operations, warehouse logistics, insurance, workflows, and even working on bringing AI solutions to designing printed circuit boards,” Varadharajanis said. “So a lot of creative ways in which companies are applying AI to solve different issues in different industries.”

Image Credit: Butterfly Network Continue reading →

Posted in Human Robots

#436491 The Year’s Most Fascinating Tech ...

Posted on January 4, 2020 by Android

Last Saturday we took a look at some of the most-read Singularity Hub articles from 2019. This week, we’re featuring some of our favorite articles from the last year. As opposed to short pieces about what’s happening, these are long reads about why it matters and what’s coming next. Some of them make the news while others frame the news, go deep on big ideas, go behind the scenes, or explore the human side of technological progress.

We hope you find them as fascinating, inspiring, and illuminating as we did.

DeepMind and Google: The Battle to Control Artificial Intelligence
Hal Hodson | 1843
“[DeepMind cofounder and CEO Demis] Hassabis thought DeepMind would be a hybrid: it would have the drive of a startup, the brains of the greatest universities, and the deep pockets of one of the world’s most valuable companies. Every element was in place to hasten the arrival of [artificial general intelligence] and solve the causes of human misery.”

The Most Powerful Person in Silicon Valley
Katrina Brooker | Fast Company
“Billionaire Masayoshi Son—not Elon Musk, Jeff Bezos, or Mark Zuckerberg—has the most audacious vision for an AI-powered utopia where machines control how we live. And he’s spending hundreds of billions of dollars to realize it. Are you ready to live in Masa World?”

AR Will Spark the Next Big Tech Platform—Call It Mirrorworld
Kevin Kelly | Wired
“Eventually this melded world will be the size of our planet. It will be humanity’s greatest achievement, creating new levels of wealth, new social problems, and uncountable opportunities for billions of people. There are no experts yet to make this world; you are not late.”

Behind the Scenes of a Radical New Cancer Cure
Ilana Yurkiewicz | Undark
“I remember the first time I watched a patient get his Day 0 infusion. It felt anti-climactic. The entire process took about 15 minutes. The CAR-T cells are invisible to the naked eye, housed in a small plastic bag containing clear liquid. ‘That’s it?’ my patient asked when the nurse said it was over. The infusion part is easy. The hard part is everything that comes next.”

The Promise and Price of Cellular Therapies
Siddhartha Mukherjee | The New Yorker
“We like to imagine medical revolutions as, well, revolutionary—propelled forward through leaps of genius and technological innovation. But they are also evolutionary, nudged forward through the optimization of design and manufacture.”

Impossible Foods’ Rising Empire of Almost Meat
Chris Ip | Engadget
“Impossible says it wants to ultimately create a parallel universe of ersatz animal products from steak to eggs. …Yet as Impossible ventures deeper into the culinary uncanny valley, it also needs society to discard a fundamental cultural idea that dates back millennia and accept a new truth: Meat doesn’t have to come from animals.”

Inside the Amazon Warehouse Where Humans and Machines Become One
Matt Simon | Wired
“Seen from above, the scale of the system is dizzying. My robot, a little orange slab known as a ‘drive’ (or more formally and mythically, Pegasus), is just one of hundreds of its kind swarming a 125,000-square-foot ‘field’ pockmarked with chutes. It’s a symphony of electric whirring, with robots pausing for one another at intersections and delivering their packages to the slides.”

Boston Dynamics’ Robots Are Preparing to Leave the Lab—Is the World Ready?
James Vincent | The Verge
“After decades of kicking machines in parking lots, the company is set to launch its first ever commercial bot later this year: the quadrupedal Spot. It’s a crucial test for a company that’s spent decades pursuing long-sighted R&D. And more importantly, the success—or failure—of Spot will tell us a lot about our own robot future. Are we ready for machines to walk among us?”

I Cut the ‘Big Five’ Tech Giants From My Life. It Was Hell
Kashmir Hill | Gizmodo
“Critics of the big tech companies are often told, ‘If you don’t like the company, don’t use its products.’ I did this experiment to find out if that is possible, and I found out that it’s not—with the exception of Apple. …These companies are unavoidable because they control internet infrastructure, online commerce, and information flows.”

Why I (Still) Love Tech: In Defense of a Difficult Industry
Paul Ford | Wired
“The mysteries of software caught my eye when I was a boy, and I still see it with the same wonder, even though I’m now an adult. Proudshamed, yes, but I still love it, the mess of it, the code and toolkits, down to the pixels and the processors, and up to the buses and bridges. I love the whole made world. But I can’t deny that the miracle is over, and that there is an unbelievable amount of work left for us to do.”

The Peculiar Blindness of Experts
David Epstein | The Atlantic
“In business, esteemed (and lavishly compensated) forecasters routinely are wildly wrong in their predictions of everything from the next stock-market correction to the next housing boom. Reliable insight into the future is possible, however. It just requires a style of thinking that’s uncommon among experts who are certain that their deep knowledge has granted them a special grasp of what is to come.”

The Most Controversial Tree in the World
Rowan Jacobson | Pacific Standard
“…we are all GMOs, the beneficiaries of freakishly unlikely genetic mash-ups, and the real Island of Dr. Moreau is that blue-green botanical garden positioned third from the sun. Rather than changing the nature of nature, as I once thought, this might just be the very nature of nature.”

How an Augmented Reality Game Escalated Into Real-World Spy Warfare
Elizabeth Ballou | Vice
“In Ingress, players accept that every park and train station could be the site of an epic showdown, but that’s only the first step. The magic happens when other people accept that, too. When players feel like that magic is real, there are few limits to what they’ll do or where they’ll go for the sake of the game. ”

The Shady Cryptocurrency Boom on the Post-Soviet Frontier
Hannah Lucinda Smith | Wired
“…although the tourists won’t guess it as they stand at Kuchurgan’s gates, admiring how the evening light reflects off the silver plaque of Lenin, this plant is pumping out juice to a modern-day gold rush: a cryptocurrency boom that is underway all across the former Soviet Union, from the battlefields of eastern Ukraine to time-warp enclaves like Transnistria and freshly annexed Crimea.”

Scientists Are Totally Rethinking Animal Cognition
Ross Andersen | The Atlantic
“This idea that animals are conscious was long unpopular in the West, but it has lately found favor among scientists who study animal cognition. …For many scientists, the resonant mystery is no longer which animals are conscious, but which are not.”

I Wrote This on a 30-Year-Old Computer
Ian Bogost | The Atlantic
“[Back then] computing was an accompaniment to life, rather than the sieve through which all ideas and activities must filter. That makes using this 30-year-old device a surprising joy, one worth longing for on behalf of what it was at the time, rather than for the future it inaugurated.”

Image Credit: Wes Hicks / Unsplash Continue reading →

Posted in Human Robots

#436256 Alphabet Is Developing a Robot to Take ...

Posted on December 2, 2019 by Android

Robots excel at carrying out specialized tasks in controlled environments, but put them in your average office and they’d be lost. Alphabet wants to change that by developing what they call the Everyday Robot, which could learn to help us out with our daily chores.

For a long time most robots were painstakingly hand-coded to carry out their functions, but since the deep learning revolution earlier this decade there’s been a growing effort to imbue them with AI that lets them learn new tasks through experience.

That’s led to some impressive breakthroughs, like a robotic hand nimble enough to solve a Rubik’s cube and a robotic arm that can accurately toss bananas across a room.

And it turns out Alphabet’s early-stage research and development division, Alphabet X, has also secretly been using similar machine learning techniques to develop robots adaptable enough to carry out a range of tasks in cluttered and unpredictable human environments like homes and offices.

The robots they’ve built combine a wheeled base with a single arm and a head full of sensors (including LIDAR) for 3D scanning, borrowed from Alphabet’s self-driving car division, Waymo.

At the minute, though, they’re largely restricted to sorting trash for recycling, project leader Hans Peter Brondmo writes in a blog post. While that might sound mundane, identifying different kinds of trash, grasping it, and moving it to the correct bin is still a difficult thing for a robot to do consistently. Some of the robots also have to navigate around the office to sort trash at various recycling stations.

Alphabet says even its human staff were getting it wrong 20 percent of the time, but after several months of training the robots have managed to get that down to 3.5 percent.

Every day, 30 robots toil away in what’s been dubbed the “playpen” sorting trash, and then every night thousands of virtual robots continue to practice in a simulation. This experience is then used to update the robots’ control algorithms each night. All the robots also share their experiences with the others through a process called collaborative learning.

The process isn’t flawless, though. Simonite notes that while the robots exhibit some uncannily smart behaviors, like stirring piles of rubbish to make it easier to grab specific items, they also frequently miss or fumble the objects they’re trying to grasp.

Nonetheless, the project’s leaders are happy with their progress so far. And the hope is that creating robots that are able to learn from little more than experience in complex environments like an office should be a first step towards general-purpose robots that can pick up a variety of useful skills to assist humans.

Taking that next step will be the major test of the project. So far there’s been limited evidence that experience gained by robots in one task can be transferred to learning another. That’s something the group hopes to demonstrate next year.

And it seems there may be more robot news coming out of Alphabet X soon. The group has several other robotics “moonshots” in the pipeline, built on technology and talent transferred over in 2016 from the remains of a broadly unsuccessful splurge on robotics startups by former Google executive Andy Rubin.

Whether this robotics renaissance at Alphabet will finally help robots break into our homes and offices remains to be seen, but with the resources they have at hand, they just may be able to make it happen.

Image Credit: Everyday Robot, Alphabet X Continue reading →

Posted in Human Robots

#436188 The Blogger Behind “AI ...

Posted on November 21, 2019 by Android

Sure, artificial intelligence is transforming the world’s societies and economies—but can an AI come up with plausible ideas for a Halloween costume?

Janelle Shane has been asking such probing questions since she started her AI Weirdness blog in 2016. She specializes in training neural networks (which underpin most of today’s machine learning techniques) on quirky data sets such as compilations of knitting instructions, ice cream flavors, and names of paint colors. Then she asks the neural net to generate its own contributions to these categories—and hilarity ensues. AI is not likely to disrupt the paint industry with names like “Ronching Blue,” “Dorkwood,” and “Turdly.”

Shane’s antics have a serious purpose. She aims to illustrate the serious limitations of today’s AI, and to counteract the prevailing narrative that describes AI as well on its way to superintelligence and complete human domination. “The danger of AI is not that it’s too smart,” Shane writes in her new book, “but that it’s not smart enough.”

The book, which came out on Tuesday, is called You Look Like a Thing and I Love You. It takes its odd title from a list of AI-generated pick-up lines, all of which would at least get a person’s attention if shouted, preferably by a robot, in a crowded bar. Shane’s book is shot through with her trademark absurdist humor, but it also contains real explanations of machine learning concepts and techniques. It’s a painless way to take AI 101.

She spoke with IEEE Spectrum about the perils of placing too much trust in AI systems, the strange AI phenomenon of “giraffing,” and her next potential Halloween costume.

Janelle Shane on . . .

The un-delicious origin of her blog
“The narrower the problem, the smarter the AI will seem”
Why overestimating AI is dangerous
Giraffing!
Machine and human creativity

The un-delicious origin of her blog IEEE Spectrum: You studied electrical engineering as an undergrad, then got a master’s degree in physics. How did that lead to you becoming the comedian of AI?
Janelle Shane: I’ve been interested in machine learning since freshman year of college. During orientation at Michigan State, a professor who worked on evolutionary algorithms gave a talk about his work. It was full of the most interesting anecdotes–some of which I’ve used in my book. He told an anecdote about people setting up a machine learning algorithm to do lens design, and the algorithm did end up designing an optical system that works… except one of the lenses was 50 feet thick, because they didn’t specify that it couldn’t do that.
I started working in his lab on optics, doing ultra-short laser pulse work. I ended up doing a lot more optics than machine learning, but I always found it interesting. One day I came across a list of recipes that someone had generated using a neural net, and I thought it was hilarious and remembered why I thought machine learning was so cool. That was in 2016, ages ago in machine learning land.
Spectrum: So you decided to “establish weirdness as your goal” for your blog. What was the first weird experiment that you blogged about?
Shane: It was generating cookbook recipes. The neural net came up with ingredients like: “Take ¼ pounds of bones or fresh bread.” That recipe started out: “Brown the salmon in oil, add creamed meat to the mixture.” It was making mistakes that showed the thing had no memory at all.
Spectrum: You say in the book that you can learn a lot about AI by giving it a task and watching it flail. What do you learn?
Shane: One thing you learn is how much it relies on surface appearances rather than deep understanding. With the recipes, for example: It got the structure of title, category, ingredients, instructions, yield at the end. But when you look more closely, it has instructions like “Fold the water and roll it into cubes.” So clearly this thing does not understand water, let alone the other things. It’s recognizing certain phrases that tend to occur, but it doesn’t have a concept that these recipes are describing something real. You start to realize how very narrow the algorithms in this world are. They only know exactly what we tell them in our data set.
BACK TO TOP↑ “The narrower the problem, the smarter the AI will seem” Spectrum: That makes me think of DeepMind’s AlphaGo, which was universally hailed as a triumph for AI. It can play the game of Go better than any human, but it doesn’t know what Go is. It doesn’t know that it’s playing a game.
Shane: It doesn’t know what a human is, or if it’s playing against a human or another program. That’s also a nice illustration of how well these algorithms do when they have a really narrow and well-defined problem.
The narrower the problem, the smarter the AI will seem. If it’s not just doing something repeatedly but instead has to understand something, coherence goes down. For example, take an algorithm that can generate images of objects. If the algorithm is restricted to birds, it could do a recognizable bird. If this same algorithm is asked to generate images of any animal, if its task is that broad, the bird it generates becomes an unrecognizable brown feathered smear against a green background.
Spectrum: That sounds… disturbing.
Shane: It’s disturbing in a weird amusing way. What’s really disturbing is the humans it generates. It hasn’t seen them enough times to have a good representation, so you end up with an amorphous, usually pale-faced thing with way too many orifices. If you asked it to generate an image of a person eating pizza, you’ll have blocks of pizza texture floating around. But if you give that image to an image-recognition algorithm that was trained on that same data set, it will say, “Oh yes, that’s a person eating pizza.”
BACK TO TOP↑ Why overestimating AI is dangerous Spectrum: Do you see it as your role to puncture the AI hype?
Shane: I do see it that way. Not a lot of people are bringing out this side of AI. When I first started posting my results, I’d get people saying, “I don’t understand, this is AI, shouldn’t it be better than this? Why doesn't it understand?” Many of the impressive examples of AI have a really narrow task, or they’ve been set up to hide how little understanding it has. There’s a motivation, especially among people selling products based on AI, to represent the AI as more competent and understanding than it actually is.
Spectrum: If people overestimate the abilities of AI, what risk does that pose?
Shane: I worry when I see people trusting AI with decisions it can’t handle, like hiring decisions or decisions about moderating content. These are really tough tasks for AI to do well on. There are going to be a lot of glitches. I see people saying, “The computer decided this so it must be unbiased, it must be objective.”

“If the algorithm’s task is to replicate human hiring decisions, it’s going to glom onto gender bias and race bias.”
—Janelle Shane, AI Weirdness blogger
That’s another thing I find myself highlighting in the work I’m doing. If the data includes bias, the algorithm will copy that bias. You can’t tell it not to be biased, because it doesn’t understand what bias is. I think that message is an important one for people to understand.
If there’s bias to be found, the algorithm is going to go after it. It’s like, “Thank goodness, finally a signal that’s reliable.” But for a tough problem like: Look at these resumes and decide who’s best for the job. If its task is to replicate human hiring decisions, it’s going to glom onto gender bias and race bias. There’s an example in the book of a hiring algorithm that Amazon was developing that discriminated against women, because the historical data it was trained on had that gender bias.
Spectrum: What are the other downsides of using AI systems that don’t really understand their tasks?
Shane: There is a risk in putting too much trust in AI and not examining its decisions. Another issue is that it can solve the wrong problems, without anyone realizing it. There have been a couple of cases in medicine. For example, there was an algorithm that was trained to recognize things like skin cancer. But instead of recognizing the actual skin condition, it latched onto signals like the markings a surgeon makes on the skin, or a ruler placed there for scale. It was treating those things as a sign of skin cancer. It’s another indication that these algorithms don’t understand what they’re looking at and what the goal really is.
BACK TO TOP↑ Giraffing Spectrum: In your blog, you often have neural nets generate names for things—such as ice cream flavors, paint colors, cats, mushrooms, and types of apples. How do you decide on topics?
Shane: Quite often it’s because someone has written in with an idea or a data set. They’ll say something like, “I’m the MIT librarian and I have a whole list of MIT thesis titles.” That one was delightful. Or they’ll say, “We are a high school robotics team, and we know where there’s a list of robotics team names.” It’s fun to peek into a different world. I have to be careful that I’m not making fun of the naming conventions in the field. But there’s a lot of humor simply in the neural net’s complete failure to understand. Puns in particular—it really struggles with puns.
Spectrum: Your blog is quite absurd, but it strikes me that machine learning is often absurd in itself. Can you explain the concept of giraffing?
Shane: This concept was originally introduced by [internet security expert] Melissa Elliott. She proposed this phrase as a way to describe the algorithms’ tendency to see giraffes way more often than would be likely in the real world. She posted a whole bunch of examples, like a photo of an empty field in which an image-recognition algorithm has confidently reported that there are giraffes. Why does it think giraffes are present so often when they’re actually really rare? Because they’re trained on data sets from online. People tend to say, “Hey look, a giraffe!” And then take a photo and share it. They don’t do that so often when they see an empty field with rocks.
There’s also a chatbot that has a delightful quirk. If you show it some photo and ask it how many giraffes are in the picture, it will always answer with some non zero number. This quirk comes from the way the training data was generated: These were questions asked and answered by humans online. People tended not to ask the question “How many giraffes are there?” when the answer was zero. So you can show it a picture of someone holding a Wii remote. If you ask it how many giraffes are in the picture, it will say two.
BACK TO TOP↑ Machine and human creativity Spectrum: AI can be absurd, and maybe also creative. But you make the point that AI art projects are really human-AI collaborations: Collecting the data set, training the algorithm, and curating the output are all artistic acts on the part of the human. Do you see your work as a human-AI art project?
Shane: Yes, I think there is artistic intent in my work; you could call it literary or visual. It’s not so interesting to just take a pre-trained algorithm that’s been trained on utilitarian data, and tell it to generate a bunch of stuff. Even if the algorithm isn’t one that I’ve trained myself, I think about, what is it doing that’s interesting, what kind of story can I tell around it, and what do I want to show people.

The Halloween costume algorithm “was able to draw on its knowledge of which words are related to suggest things like sexy barnacle.”
—Janelle Shane, AI Weirdness blogger
Spectrum: For the past three years you’ve been getting neural nets to generate ideas for Halloween costumes. As language models have gotten dramatically better over the past three years, are the costume suggestions getting less absurd?
Shane: Yes. Before I would get a lot more nonsense words. This time I got phrases that were related to real things in the data set. I don’t believe the training data had the words Flying Dutchman or barnacle. But it was able to draw on its knowledge of which words are related to suggest things like sexy barnacle and sexy Flying Dutchman.
Spectrum: This year, I saw on Twitter that someone made the gothy giraffe costume happen. Would you ever dress up for Halloween in a costume that the neural net suggested?
Shane: I think that would be fun. But there would be some challenges. I would love to go as the sexy Flying Dutchman. But my ambition may constrict me to do something more like a list of leg parts.
BACK TO TOP↑ Continue reading →

Posted in Human Robots